{
    "2020-04-06": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Alnylam, Dicerna Join Forces to Take on Arrowhead",
                "features": {
                    "keywords": [
                        "Alnylam",
                        "Dicerna",
                        "partnership",
                        "Arrowhead",
                        "biotech"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Novo Nordisk's Rybelsus Gets EU Nod for Type II Diabetes",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Rybelsus",
                        "EU approval",
                        "Type II Diabetes",
                        "pharmaceuticals"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Highlights From Fundsmith Equity Fundâ€™s 2020 Investor Letter",
                "features": {
                    "keywords": [
                        "Fundsmith",
                        "Equity Fund",
                        "investor letter",
                        "investment strategy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "investment"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}